# A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

> **NCT07422337** · — · RECRUITING · sponsor: **Arkansas Children's Hospital Research Institute** · enrollment: 300 (estimated)

## Conditions studied

- B-Cell ALL
- B-Cell Acute Lymphoblastic Leukaemia
- B-Cell Lymphoblastic Leukemia
- B-Cell Lymphoblastic Leukemia/Lymphoma
- B-cell Acute Lymphoblastic Leukemia (B-ALL)
- B-cell Acute Lymphoblastic Leukemia
- B-cell Childhood Acute Lymphoblastic Leukemia
- B-cell Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07422337
- **Lead sponsor:** Arkansas Children's Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-13
- **Primary completion:** 2028-01
- **Final completion:** 2029-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07422337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07422337, "A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07422337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*